Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Ribosomal protein S10 pseudogene 7" (RPS10P7) is a processed pseudogene of the RPS10 gene and is not known to code for a functional protein[1][3]. Some literature and functional studies refer to "lnc-MCEI" as a long non-coding RNA implicated in the modulation of chemosensitivity in esophageal squamous cell carcinoma, potentially by regulating IGF2; however, this function and naming are not standardized in genetic or pharmacological databases. As a processed pseudogene, RPS10P7 lacks protein-coding ability and its molecular and biological relevance, outside of limited research contexts as a non-coding RNA or biomarker, remains unclear. Many long non-coding RNAs are involved in gene regulation, chromatin modification, cell cycle control, and cancer, but most remain poorly characterized and are not recognized as therapeutic targets in drug discovery paradigms[2][4][6][8].
Regulation of chemosensitivity (via IGF2 modulation implied by the functional alias; specific molecular mechanisms are not fully detailed in retrieved sources)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S10 pseudogene 7 (RPS10P7).